ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest hepatitis b news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks hepatitis b across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AusperBio secured $120 million in Series C funding to advance chronic hepatitis B therapies. The biopharma firm will use the capital to progress its clinical pipeline. The financing supports development of treatments targeting the chronic liver infection.
Summaries by ByteBrief